225
Views
4
CrossRef citations to date
0
Altmetric
Drug Evaluation

Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia

, PhD Bsc(hons) &
Pages 1085-1092 | Published online: 21 May 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdulgabar Salama. (2017) Emerging drugs for immune thrombocytopenia (ITP). Expert Opinion on Emerging Drugs 22:1, pages 27-38.
Read now
Alan H Lazarus. (2013) Monoclonal versus polyclonal anti-D in the treatment of ITP. Expert Opinion on Biological Therapy 13:10, pages 1353-1356.
Read now

Articles from other publishers (2)

Yue Lv, Huiping Shi, Hong Liu & Lu Zhou. (2022) Current therapeutic strategies and perspectives in refractory ITP: What have we learned recently?. Frontiers in Immunology 13.
Crossref
Lidice Bernardo, Alaa Amash, Danielle Marjoram & Alan H. Lazarus. (2016) Antibody-mediated immune suppression is improved when blends of anti-RBC monoclonal antibodies are used in mice. Blood 128:8, pages 1076-1080.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.